Immediate Impact
3 by Nobel laureates 4 from Science/Nature 53 standout
Citing Papers
Thirty years of NRF2: advances and therapeutic challenges
2025 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Christopher Kallus being referenced
Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Christopher Kallus | 286 | 241 | 29 | 12 | 387 | |
| Yasunori Funabashi | 175 | 200 | 68 | 15 | 343 | |
| Christophe Labrière | 146 | 83 | 32 | 14 | 336 | |
| Michael P. Kirkup | 138 | 239 | 43 | 21 | 400 | |
| K. ISONO | 281 | 102 | 77 | 17 | 420 | |
| Shawn E. Ramer | 311 | 54 | 56 | 13 | 404 | |
| Maureen Laney | 129 | 163 | 60 | 15 | 364 | |
| Rafael A. Espiritu | 251 | 34 | 34 | 16 | 400 | |
| Anne-Laure Gagez | 118 | 46 | 35 | 16 | 372 | |
| Selwyn C. Yorke | 135 | 153 | 32 | 24 | 371 | |
| Paul J. Hodges | 189 | 211 | 57 | 17 | 441 |
All Works
Loading papers...